1. Home
  2. SAVA vs SPRU Comparison

SAVA vs SPRU Comparison

Compare SAVA & SPRU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cassava Sciences Inc.

SAVA

Cassava Sciences Inc.

HOLD

Current Price

$2.13

Market Cap

96.1M

Sector

Health Care

ML Signal

HOLD

Logo Spruce Power Holding Corporation

SPRU

Spruce Power Holding Corporation

HOLD

Current Price

$4.58

Market Cap

93.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAVA
SPRU
Founded
1998
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
96.1M
93.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SAVA
SPRU
Price
$2.13
$4.58
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
772.9K
111.2K
Earning Date
03-02-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$108,010,000.00
Revenue This Year
N/A
$2.12
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
39.22
52 Week Low
$1.15
$1.13
52 Week High
$4.98
$6.75

Technical Indicators

Market Signals
Indicator
SAVA
SPRU
Relative Strength Index (RSI) 47.99 31.51
Support Level $2.04 $4.96
Resistance Level $2.22 $6.75
Average True Range (ATR) 0.11 0.49
MACD 0.03 -0.21
Stochastic Oscillator 62.86 0.00

Price Performance

Historical Comparison
SAVA
SPRU

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

About SPRU Spruce Power Holding Corporation

Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.

Share on Social Networks: